| Product Code: ETC8279625 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Gastric Cancer Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Gastric Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Gastric Cancer Market - Industry Life Cycle |
3.4 Mexico Gastric Cancer Market - Porter's Five Forces |
3.5 Mexico Gastric Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Gastric Cancer Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.7 Mexico Gastric Cancer Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Mexico Gastric Cancer Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Mexico Gastric Cancer Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Mexico Gastric Cancer Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Mexico Gastric Cancer Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Gastric Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of gastric cancer in Mexico |
4.2.2 Technological advancements in diagnostic and treatment options for gastric cancer |
4.2.3 Growing awareness among the population about the importance of early detection and treatment of gastric cancer |
4.3 Market Restraints |
4.3.1 Limited access to quality healthcare services in certain regions of Mexico |
4.3.2 High cost of advanced treatments and therapies for gastric cancer |
4.3.3 Cultural factors leading to delayed diagnosis and treatment of gastric cancer in some communities |
5 Mexico Gastric Cancer Market Trends |
6 Mexico Gastric Cancer Market, By Types |
6.1 Mexico Gastric Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Gastric Cancer Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mexico Gastric Cancer Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.1.4 Mexico Gastric Cancer Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 Mexico Gastric Cancer Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F |
6.1.6 Mexico Gastric Cancer Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F |
6.1.7 Mexico Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Gastric Cancer Market, By Stages |
6.2.1 Overview and Analysis |
6.2.2 Mexico Gastric Cancer Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.3 Mexico Gastric Cancer Market Revenues & Volume, By Stage II, 2021- 2031F |
6.2.4 Mexico Gastric Cancer Market Revenues & Volume, By Stage III, 2021- 2031F |
6.2.5 Mexico Gastric Cancer Market Revenues & Volume, By Stage IV, 2021- 2031F |
6.2.6 Mexico Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Gastric Cancer Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Mexico Gastric Cancer Market Revenues & Volume, By Endoscopy, 2021- 2031F |
6.3.3 Mexico Gastric Cancer Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.4 Mexico Gastric Cancer Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.3.5 Mexico Gastric Cancer Market Revenues & Volume, By Exploratory Surgery, 2021- 2031F |
6.3.6 Mexico Gastric Cancer Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Mexico Gastric Cancer Market, By Treatment |
6.4.1 Overview and Analysis |
6.4.2 Mexico Gastric Cancer Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 Mexico Gastric Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Mexico Gastric Cancer Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.5 Mexico Gastric Cancer Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.6 Mexico Gastric Cancer Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.4.7 Mexico Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Gastric Cancer Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Mexico Gastric Cancer Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Mexico Gastric Cancer Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.4 Mexico Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mexico Gastric Cancer Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Mexico Gastric Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Mexico Gastric Cancer Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Mexico Gastric Cancer Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.6.5 Mexico Gastric Cancer Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Mexico Gastric Cancer Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Mexico Gastric Cancer Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Mexico Gastric Cancer Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 Mexico Gastric Cancer Market Revenues & Volume, By , 2021- 2031F |
7 Mexico Gastric Cancer Market Import-Export Trade Statistics |
7.1 Mexico Gastric Cancer Market Export to Major Countries |
7.2 Mexico Gastric Cancer Market Imports from Major Countries |
8 Mexico Gastric Cancer Market Key Performance Indicators |
8.1 Survival rates of patients diagnosed with gastric cancer in Mexico |
8.2 Adoption rates of new diagnostic technologies for gastric cancer screening |
8.3 Number of healthcare facilities offering specialized gastric cancer treatment services |
9 Mexico Gastric Cancer Market - Opportunity Assessment |
9.1 Mexico Gastric Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Gastric Cancer Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.3 Mexico Gastric Cancer Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Mexico Gastric Cancer Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.5 Mexico Gastric Cancer Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Mexico Gastric Cancer Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Mexico Gastric Cancer Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Gastric Cancer Market - Competitive Landscape |
10.1 Mexico Gastric Cancer Market Revenue Share, By Companies, 2024 |
10.2 Mexico Gastric Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here